所有图片(1)
About This Item
经验公式（希尔记法）:
C8H10N4O2
CAS号:
分子量:
194.19
Beilstein:
17705
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
等级
pharmaceutical primary standard
API类
pentoxifylline, caffeine, dimenhydrinate
制造商/商品名称
USP
mp
234-236.5 °C (lit.)
应用
pharmaceutical (small molecule)
格式
neat
SMILES字符串
CN1C(=O)N(C)c2ncn(C)c2C1=O
InChI
1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3
InChI key
RYYVLZVUVIJVGH-UHFFFAOYSA-N
基因信息
human ... ADORA1(134) , ADORA2A(135) , ADORA2B(136) , ADORA3(140)
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Caffeine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Caffeine Citrate Injection
- Caffeine Citrate Oral Solution
- Acetaminophen and Caffeine Tablets
- Ergotamine Tartrate and Caffeine Tablets
- Butalbital, Aspirin, and Caffeine Capsules
- Ergotamine Tartrate and Caffeine Suppositories
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
相关产品
产品编号
说明
价格
警示用语：
Warning
危险声明
预防措施声明
危险分类
Acute Tox. 4 Oral
储存分类代码
13 - Non Combustible Solids
WGK
WGK 1
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
Caffeine Citrate Oral Solution
United States Pharmacopeia, 30(5), 663-663 (2013)
Quantitative reversed-phase high-performance liquid chromatographic analysis of ampicillin
Margosis M, et al.
Journal of Chromatography A, 236(2), 461-468 (1982)
Acetaminophen and Caffeine Tablets
United States Pharmacopeia, 41(2), 51-51 (2020)
Ergotamine Tartrate and Caffeine Tablets
United States Pharmacopeia, 40(1), 1681-1681 (2015)
Caffeine
United States Pharmacopeia, 49(2), 661-661 (2020)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门